Showing results (301-310 of 459) with videos related to

Sort By:
Pageof 46
Modern Rheumatology|December 15, 2021
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1)Yoshiya Tanaka, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 13, 2021
Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and ApoptosisBhupinder Singh, Guru P Maiti, Xujie Zhou, et al.
Annals of the Rheumatic Diseases|February 1, 2025
Genetic burden of lupus increases the risk of transition from normal to preclinical autoimmune conditions via antinuclear antibody developmentSehwan Chun, So-Young Bang, Ayeong Kwon, et al.
International Journal of Rheumatic Diseases|January 25, 2019
Clinical outcomes of patients with active rheumatoid arthritis with normal acute phase reactant valuesMin Kyung Chung, Bohyun Park, In Je Kim, et al.
Experimental & Molecular Medicine|July 31, 2025
Tracking clonal dynamics of CD8 T cells and immune dysregulation in progression of systemic lupus erythematosus with nephritisSeung-Jun Paek, Hye-Soon Lee, Ye Ji Lee, et al.
Modern Rheumatology|December 11, 2013
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and JapanSoo-Kyung Cho, Ryoko Sakai, Toshihiro Nanki, et al.
Arthritis and Rheumatism|March 2, 2011
Association of a functional IRF7 variant with systemic lupus erythematosusQiong Fu, Jian Zhao, Xiaoxia Qian, et al.
The Journal of Rheumatology|January 17, 2018
Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus ErythematosusSasha Bernatsky, Rosalind Ramsey-Goldman, Michelle Petri, et al.
Human Molecular Genetics|January 22, 2017
Confirmation of five novel susceptibility loci for systemic lupus erythematosus (SLE) and integrated network analysis of 82 SLE susceptibility lociJulio E Molineros, Wanling Yang, Xu-Jie Zhou, et al.
The Korean Journal of Internal Medicine|January 4, 2018
Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritisYoung Mo Kang, Young-Eun Park, Won Park, et al.
Pageof 46